Zobrazeno 1 - 10
of 882
pro vyhledávání: '"REDUCING SALPINGO-OOPHORECTOMY"'
Autor:
Jihye Kim, Chel Hun Choi
Publikováno v:
Obstetrics & Gynecology Science, Vol 67, Iss 4, Pp 343-355 (2024)
Significant progress has been made in the molecular diagnosis of cancer. It provides personalized medicine, including cancer diagnosis, prognosis, targeted therapy, and risk detection. These advances allow physicians to identify patients at risk for
Externí odkaz:
https://doaj.org/article/ed00cbdbef98430b821810f02a40994e
Autor:
Aya Tanaka, Megumi Matsumoto, Mami Takao, Shoko Miura, Yuri Hasegawa, Ryota Otsubo, Hiroko Hayashi, Ichiro Isomoto, Kiyonori Miura, Takeshi Nagayasu
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 21, Iss 1, Pp 1-7 (2023)
Abstract Background In Japan, genetic testing, surveillance, and risk-reducing surgery for hereditary breast and ovarian cancer (HBOC) syndrome have been covered by the Japanese national insurance system since April 2020. On the other hand, the curre
Externí odkaz:
https://doaj.org/article/6dec25dad03446f4a033d672480e2e19
Publikováno v:
Journal of Ovarian Research, Vol 16, Iss 1, Pp 1-8 (2023)
Abstract Background Risk-reducing salpingo-oophorectomy (RRSO) is recommended for women at increased risk of breast and ovarian cancer. We launched a prospective study of women receiving RRSO, including those with mutations in genes beyond BRCA1/2. P
Externí odkaz:
https://doaj.org/article/024c1f228d9046e59eb3ba2638ffc051
Autor:
Katsuyuki Konnai, Hiroyuki Fujiwara, Masakazu Kitagawa, Reina Wakabayashi, Asuna Yumori, Tsuguto Notomi, Ryo Onose, Hisamori Kato, Hiroto Narimatsu
Publikováno v:
Archives of Public Health, Vol 81, Iss 1, Pp 1-9 (2023)
Abstract Background In April 2020, insurance coverage for risk-reducing salpingo-oophorectomy (RRSO) for breast cancer patients with hereditary breast and ovarian cancer (HBOC) syndrome and BRCA testing were started in Japan. We investigated the impa
Externí odkaz:
https://doaj.org/article/03fe87f9f291432db95ac998a7a00836
Publikováno v:
Current Oncology, Vol 30, Iss 2, Pp 2429-2440 (2023)
Risk-reducing bilateral salpingo-oophorectomy (RRSO) is an effective prophylactic surgery provided to premenopausal women carrying BRCA1 or BRCA2 mutations and presenting an increased risk of developing breast or ovarian cancer. This procedure is rel
Externí odkaz:
https://doaj.org/article/96ce054a2b4a4e978aef63af23a2062b
Autor:
FENG Zheng, WEN Hao
Publikováno v:
Zhongguo aizheng zazhi, Vol 32, Iss 11, Pp 1044-1048 (2022)
Ovarian cancer is one of the most common and lethal diseases among females. Due to the difficulty of surveillance and early detection, most ovarian cancers were diagnosed at advanced stage with poor outcomes. Epidemiological studies indicate that wom
Externí odkaz:
https://doaj.org/article/093fee4116f94a65ba49c3e9a50379bd
Autor:
Maria Colomba Comes, Francesca Arezzo, Gennaro Cormio, Samantha Bove, Angela Calabrese, Annarita Fanizzi, Anila Kardhashi, Daniele La Forgia, Francesco Legge, Isabella Romagno, Vera Loizzi, Raffaella Massafra
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionIt has been estimated that 19,880 new cases of ovarian cancer had been diagnosed in 2022. Most epithelial ovarian cancer are sporadic, while in 15%–25% of cases, there is evidence of a familial or inherited component. Approximately 20%
Externí odkaz:
https://doaj.org/article/e4ee8236009f4e84b00a2a07a5bfbd04
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hiba A. Moukadem, Ahmad Al Masry, Rula W. Atwani, Firas Kreidieh, Lana E. Khalil, Rita Saroufim, Sarah Daouk, Iman Abou Dalle, Nagi S. El Saghir
Publikováno v:
European Journal of Breast Health, Vol 18, Iss 1, Pp 16-20 (2022)
Objective:Worldwide genetic counseling practices are variable and often not reported in low- and middle-income countries (LMICs). We present the follow-up genetic counseling, breast screening, risk-reducing salpingo-oophorectomy (RRSO) and contralate
Externí odkaz:
https://doaj.org/article/217dab4afb9b426481e9c8a002bc79e9